3564 related articles for article (PubMed ID: 16170677)
1. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
2. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
3. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.
Francisci D; Giannini S; Baldelli F; Leone M; Belfiori B; Guglielmini G; Malincarne L; Gresele P
AIDS; 2009 Mar; 23(5):589-96. PubMed ID: 19177019
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy with heart.
Randell P; Moyle G
Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
[TBL] [Abstract][Full Text] [Related]
5. Endothelial function in HIV-infected patients with low or mild cardiovascular risk.
Blanco JJ; García IS; Cerezo JG; de Rivera JM; Anaya PM; Raya PG; García JG; López JR; Hernández FJ; Rodríguez JJ
J Antimicrob Chemother; 2006 Jul; 58(1):133-9. PubMed ID: 16702174
[TBL] [Abstract][Full Text] [Related]
6. Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy.
Kristoffersen US; Kofoed K; Kronborg G; Giger AK; Kjaer A; Lebech AM
HIV Med; 2009 Feb; 10(2):79-87. PubMed ID: 19200170
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy.
Arildsen H; Sørensen KE; Ingerslev JM; Østergaard LJ; Laursen AL
HIV Med; 2013 Jan; 14(1):1-9. PubMed ID: 22639788
[TBL] [Abstract][Full Text] [Related]
8. [Atherosclerosis in HIV-positive patients].
Neumann T; Miller M; Esser S; Gerken G; Erbel R
Z Kardiol; 2002 Nov; 91(11):879-88. PubMed ID: 12442190
[TBL] [Abstract][Full Text] [Related]
9. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
10. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
11. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
[TBL] [Abstract][Full Text] [Related]
12. Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection.
Barbaro G
Clin Ter; 2008; 159(1):51-5. PubMed ID: 18399263
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
Boccara F
AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
[TBL] [Abstract][Full Text] [Related]
14. Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.
Guzmán-Fulgencio M; Medrano J; Rallón N; Echeverria-Urabayen A; Miguel Benito J; Restrepo C; García-Álvarez M; Vispo E; San Roman J; Sánchez-Piedra C; Soriano V; Resino S
J Infect; 2011 Nov; 63(5):382-90. PubMed ID: 21855573
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
Calza L; Manfredi R; Chiodo F
J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
[TBL] [Abstract][Full Text] [Related]
17. [HIV-related cardiovascular risk factors].
Masiá M; Gutiérrez F
Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():17-23. PubMed ID: 20172411
[TBL] [Abstract][Full Text] [Related]
18. Lipid-independent effects of an estrogen-statin combination: inhibition of expression of adhesion molecules and plasminogen activator inhibitor--I in human endothelial cell cultures.
Seeger H; Wallwiener D; Mueck AO
Climacteric; 2001 Sep; 4(3):209-14. PubMed ID: 11588944
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV Infection and its therapies.
Wohl DA
Top HIV Med; 2004; 12(3):89-93. PubMed ID: 15310940
[TBL] [Abstract][Full Text] [Related]
20. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
Calza L; Manfredi R; Pocaterra D; Chiodo F
J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
